Earnings Feed
Start Free
NovoCure Ltd·4

Jun 15, 4:24 PM ET

Kirson Eilon D. 4

4 · NovoCure Ltd · Filed Jun 15, 2018

Insider Transaction Report

Form 4
Period: 2018-06-13
NovoCure LtdNVCR
Kirson Eilon D.
Chief Science Officer
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2018-06-13$14.37/sh+30,750$441,878→ 70,332 total
  • Exercise/Conversion

    Options to Buy Ordinary Shares

    2018-06-13+30,750→ 235,335 total
    Exercise: $14.37Exp: 2025-02-23→ Ordinary Shares (30,750 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2018-06-13$11.46/sh+37,500$429,750→ 107,832 total
  • Exercise/Conversion

    Options to Buy Ordinary Shares

    2018-06-13+37,500→ 37,500 total
    Exercise: $11.46Exp: 2026-02-24→ Ordinary Shares (37,500 underlying)
Footnotes (1)
  • [F1]Options exercised were fully vested as of the date hereof.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION